Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Pain Assessment in the Intensive Care Unit

Completed

Conditions: Delirium
Critical Illness

Interventions: Procedure: Repositioning

First Posted Date: 2012-06-26

Last Posted Date: 2015-12-17

Lead Sponsor: University of Chicago

Target Recruit Count: 30

Registration Number: NCT01628185

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections

Not Applicable

Terminated

Conditions: Abscess
Skin Diseases, Bacterial

Interventions: Biological: Linezolid
Biological: Clindamycin

First Posted Date: 2012-06-14

Last Posted Date: 2019-11-08

Lead Sponsor: University of Chicago

Target Recruit Count: 25

Registration Number: NCT01619410

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver Transplant

Not Applicable

Withdrawn

Conditions: Acute Kidney Injury
End Stage Kidney Disease
Liver Disease
Chronic Kidney Disease

Interventions: Procedure: Renal replacement therapy

First Posted Date: 2012-06-14

Last Posted Date: 2015-05-27

Lead Sponsor: University of Chicago

Registration Number: NCT01619449

Locations: 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States

Magnetic Resonance Imaging in Measuring the Effect of Cabozantinib in Patients With Castrate Resistant Prostate Cancer

Phase 2

Completed

Conditions: Bone Metastases
Recurrent Prostate Cancer
Stage IV Prostate Cancer
Castrate-resistant Prostate Cancer

Interventions: Drug: cabozantinib
Other: laboratory biomarker analysis
Procedure: magnetic resonance imaging

First Posted Date: 2012-05-16

Last Posted Date: 2020-03-26

Lead Sponsor: University of Chicago

Target Recruit Count: 19

Registration Number: NCT01599793

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer

Not Applicable

Terminated

Conditions: Stage IV Renal Cell Cancer
Recurrent Renal Cell Cancer
Clear Cell Renal Cell Carcinoma

Interventions: Drug: pazopanib hydrochloride
Other: laboratory biomarker analysis
Procedure: dynamic contrast-enhanced magnetic resonance imaging
Other: pharmacogenomic studies

First Posted Date: 2012-05-16

Last Posted Date: 2017-06-08

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT01599832

Locations: 🇺🇸
Illinois Cancer Care (Peoria), Peoria, Illinois, United States
🇺🇸
Decatur Memorial Hospital, Decatur, Illinois, United States
🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

and more 1 locations

Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma

Phase 2

Completed

Conditions: Malignant Peritoneal Mesothelioma

Interventions: Drug: erlotinib hydrochloride

First Posted Date: 2012-05-07

Last Posted Date: 2018-10-16

Lead Sponsor: University of Chicago

Target Recruit Count: 2

Registration Number: NCT01592383

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients

Phase 4

Terminated

Conditions: Hepatitis C

Interventions: Drug: Peginterferon alfa-2a
Drug: Ribavirin
Drug: telaprevir

First Posted Date: 2012-05-04

Last Posted Date: 2016-06-15

Lead Sponsor: University of Chicago

Target Recruit Count: 3

Registration Number: NCT01592006

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer

Phase 2

Completed

Conditions: Castration-resistant Prostate Cancer
Stage IV Prostate Cancer

Interventions: Drug: abiraterone acetate

First Posted Date: 2012-03-05

Last Posted Date: 2019-07-05

Lead Sponsor: University of Chicago

Target Recruit Count: 72

Registration Number: NCT01543776

Locations: 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Ingalls Memorial Hospital, Harvey, Illinois, United States
🇺🇸
Illinois Cancer Care, Peoria, Illinois, United States

and more 3 locations

Evaluating the Patient-Ventilator Synchrony During Mechanical Ventilation in Patients With Acute Lung Injury

Completed

Conditions: Mechanically Ventilated ICU Patients

First Posted Date: 2012-03-01

Last Posted Date: 2014-12-03

Lead Sponsor: University of Chicago

Target Recruit Count: 30

Registration Number: NCT01541514

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Susceptibility to Pathological Gambling

Not Applicable

Completed

Conditions: Pathological Gambling

Interventions: Behavioral: Mindfulness
Behavioral: Cognition

First Posted Date: 2012-02-08

Last Posted Date: 2024-08-01

Lead Sponsor: University of Chicago

Target Recruit Count: 588

Registration Number: NCT01528982

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy